Biogen, Inc. (BIIB)
190.55
-0.13
(-0.07%)
USD |
NASDAQ |
May 07, 14:28
Biogen Market Cap : 28.13B for May 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.68B |
| Gilead Sciences, Inc. | 167.20B |
| Johnson & Johnson | 535.63B |
| Eli Lilly & Co. | 872.66B |
| Apellis Pharmaceuticals, Inc. | 5.242B |
Market Cap Related Metrics
| PE Ratio | 20.45 |
| PS Ratio | 2.922 |
| Price to Book Value | 1.508 |
| Price to Free Cash Flow | 12.11 |
| Price | 190.55 |
| Earnings Yield | 4.89% |
| Operating PE Ratio | 12.24 |
| Normalized PE Ratio | 16.79 |